 | • レポートコード：MRC2Q12-16808 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、非侵襲的出生前遺伝子検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 非侵襲的出生前遺伝子検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 非侵襲的出生前遺伝子検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 非侵襲的出生前遺伝子検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの非侵襲的出生前遺伝子検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の非侵襲的出生前遺伝子検査の売上および2028年までの予測に焦点を当てています。 非侵襲的出生前遺伝子検査のグローバル主要企業には、Labcorp、Illumina、Roche、Natera、Premaitha Health、The Beijing Genomics Institute、Berry Genomics、Daan Gene、Annoroad、CapitalBio Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 非侵襲的出生前遺伝子検査市場は、タイプとアプリケーションによって区分されます。世界の非侵襲的出生前遺伝子検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 NIPTベーシックエディション、NIPTプラス 【アプリケーション別セグメント】 初産婦高齢者、生殖補助人口、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 非侵襲的出生前遺伝子検査製品概要 - タイプ別市場（NIPTベーシックエディション、NIPTプラス） - アプリケーション別市場（初産婦高齢者、生殖補助人口、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の非侵襲的出生前遺伝子検査販売量予測2017-2028 - 世界の非侵襲的出生前遺伝子検査売上予測2017-2028 - 非侵襲的出生前遺伝子検査の地域別販売量 - 非侵襲的出生前遺伝子検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別非侵襲的出生前遺伝子検査販売量 - 主要メーカー別非侵襲的出生前遺伝子検査売上 - 主要メーカー別非侵襲的出生前遺伝子検査価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（NIPTベーシックエディション、NIPTプラス） - 非侵襲的出生前遺伝子検査のタイプ別販売量 - 非侵襲的出生前遺伝子検査のタイプ別売上 - 非侵襲的出生前遺伝子検査のタイプ別価格 ・アプリケーション別市場規模（初産婦高齢者、生殖補助人口、その他） - 非侵襲的出生前遺伝子検査のアプリケーション別販売量 - 非侵襲的出生前遺伝子検査のアプリケーション別売上 - 非侵襲的出生前遺伝子検査のアプリケーション別価格 ・北米市場 - 北米の非侵襲的出生前遺伝子検査市場規模（タイプ別、アプリケーション別） - 主要国別の非侵襲的出生前遺伝子検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの非侵襲的出生前遺伝子検査市場規模（タイプ別、アプリケーション別） - 主要国別の非侵襲的出生前遺伝子検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の非侵襲的出生前遺伝子検査市場規模（タイプ別、アプリケーション別） - 主要国別の非侵襲的出生前遺伝子検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の非侵襲的出生前遺伝子検査市場規模（タイプ別、アプリケーション別） - 主要国別の非侵襲的出生前遺伝子検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの非侵襲的出生前遺伝子検査市場規模（タイプ別、アプリケーション別） - 主要国別の非侵襲的出生前遺伝子検査市場規模（トルコ、サウジアラビア） ・企業情報 Labcorp、Illumina、Roche、Natera、Premaitha Health、The Beijing Genomics Institute、Berry Genomics、Daan Gene、Annoroad、CapitalBio Technology ・産業チェーン及び販売チャネル分析 - 非侵襲的出生前遺伝子検査の産業チェーン分析 - 非侵襲的出生前遺伝子検査の原材料 - 非侵襲的出生前遺伝子検査の生産プロセス - 非侵襲的出生前遺伝子検査の販売及びマーケティング - 非侵襲的出生前遺伝子検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 非侵襲的出生前遺伝子検査の産業動向 - 非侵襲的出生前遺伝子検査のマーケットドライバー - 非侵襲的出生前遺伝子検査の課題 - 非侵襲的出生前遺伝子検査の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Non-invasive Prenatal Genetic Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Non-invasive Prenatal Genetic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Non-invasive Prenatal Genetic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Non-invasive Prenatal Genetic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Non-invasive Prenatal Genetic Testing include Labcorp, Illumina, Roche, Natera, Premaitha Health, The Beijing Genomics Institute, Berry Genomics, Daan Gene and Annoroad, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Non-invasive Prenatal Genetic Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Non-invasive Prenatal Genetic Testing market. Further, it explains the major drivers and regional dynamics of the global Non-invasive Prenatal Genetic Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Labcorp
Illumina
Roche
Natera
Premaitha Health
The Beijing Genomics Institute
Berry Genomics
Daan Gene
Annoroad
CapitalBio Technology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Non-invasive Prenatal Genetic Testing Segment by Type
NIPT Basic Edition
NIPT Plus
Non-invasive Prenatal Genetic Testing Segment by Application
Elderly Primipara
Assisted Reproductive Population
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Non-invasive Prenatal Genetic Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Non-invasive Prenatal Genetic Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Non-invasive Prenatal Genetic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-invasive Prenatal Genetic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-invasive Prenatal Genetic Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Non-invasive Prenatal Genetic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Non-invasive Prenatal Genetic Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Labcorp, Illumina, Roche, Natera, Premaitha Health, The Beijing Genomics Institute, Berry Genomics, Daan Gene and Annoroad, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-invasive Prenatal Genetic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Prenatal Genetic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Prenatal Genetic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NIPT Basic Edition
1.2.3 NIPT Plus
1.3 Market by Application
1.3.1 Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Elderly Primipara
1.3.3 Assisted Reproductive Population
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Prenatal Genetic Testing Market Perspective (2017-2028)
2.2 Non-invasive Prenatal Genetic Testing Growth Trends by Region
2.2.1 Non-invasive Prenatal Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-invasive Prenatal Genetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Non-invasive Prenatal Genetic Testing Market Dynamics
2.3.1 Non-invasive Prenatal Genetic Testing Industry Trends
2.3.2 Non-invasive Prenatal Genetic Testing Market Drivers
2.3.3 Non-invasive Prenatal Genetic Testing Market Challenges
2.3.4 Non-invasive Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue (2017-2022)
3.1.2 Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Non-invasive Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Prenatal Genetic Testing Revenue
3.4 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Prenatal Genetic Testing Revenue in 2021
3.5 Non-invasive Prenatal Genetic Testing Key Players Head office and Area Served
3.6 Key Players Non-invasive Prenatal Genetic Testing Product Solution and Service
3.7 Date of Enter into Non-invasive Prenatal Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2023-2028)
5 Non-invasive Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-invasive Prenatal Genetic Testing Market Size (2017-2028)
6.2 North America Non-invasive Prenatal Genetic Testing Market Size by Type
6.2.1 North America Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
6.2.2 North America Non-invasive Prenatal Genetic Testing Market Size by Type (2023-2028)
6.2.3 North America Non-invasive Prenatal Genetic Testing Market Share by Type (2017-2028)
6.3 North America Non-invasive Prenatal Genetic Testing Market Size by Application
6.3.1 North America Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
6.3.2 North America Non-invasive Prenatal Genetic Testing Market Size by Application (2023-2028)
6.3.3 North America Non-invasive Prenatal Genetic Testing Market Share by Application (2017-2028)
6.4 North America Non-invasive Prenatal Genetic Testing Market Size by Country
6.4.1 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022)
6.4.2 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-invasive Prenatal Genetic Testing Market Size (2017-2028)
7.2 Europe Non-invasive Prenatal Genetic Testing Market Size by Type
7.2.1 Europe Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
7.2.2 Europe Non-invasive Prenatal Genetic Testing Market Size by Type (2023-2028)
7.2.3 Europe Non-invasive Prenatal Genetic Testing Market Share by Type (2017-2028)
7.3 Europe Non-invasive Prenatal Genetic Testing Market Size by Application
7.3.1 Europe Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
7.3.2 Europe Non-invasive Prenatal Genetic Testing Market Size by Application (2023-2028)
7.3.3 Europe Non-invasive Prenatal Genetic Testing Market Share by Application (2017-2028)
7.4 Europe Non-invasive Prenatal Genetic Testing Market Size by Country
7.4.1 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022)
7.4.2 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Type
8.2.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Application
8.3.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region
8.4.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-invasive Prenatal Genetic Testing Market Size (2017-2028)
9.2 Latin America Non-invasive Prenatal Genetic Testing Market Size by Type
9.2.1 Latin America Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Non-invasive Prenatal Genetic Testing Market Size by Type (2023-2028)
9.2.3 Latin America Non-invasive Prenatal Genetic Testing Market Share by Type (2017-2028)
9.3 Latin America Non-invasive Prenatal Genetic Testing Market Size by Application
9.3.1 Latin America Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Non-invasive Prenatal Genetic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Non-invasive Prenatal Genetic Testing Market Share by Application (2017-2028)
9.4 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country
9.4.1 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Type
10.2.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Application
10.3.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country
10.4.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Non-invasive Prenatal Genetic Testing Introduction
11.1.4 Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.1.5 Labcorp Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Non-invasive Prenatal Genetic Testing Introduction
11.2.4 Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.2.5 Illumina Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Non-invasive Prenatal Genetic Testing Introduction
11.3.4 Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 Natera
11.4.1 Natera Company Details
11.4.2 Natera Business Overview
11.4.3 Natera Non-invasive Prenatal Genetic Testing Introduction
11.4.4 Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.4.5 Natera Recent Developments
11.5 Premaitha Health
11.5.1 Premaitha Health Company Details
11.5.2 Premaitha Health Business Overview
11.5.3 Premaitha Health Non-invasive Prenatal Genetic Testing Introduction
11.5.4 Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.5.5 Premaitha Health Recent Developments
11.6 The Beijing Genomics Institute
11.6.1 The Beijing Genomics Institute Company Details
11.6.2 The Beijing Genomics Institute Business Overview
11.6.3 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Introduction
11.6.4 The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.6.5 The Beijing Genomics Institute Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Non-invasive Prenatal Genetic Testing Introduction
11.7.4 Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.7.5 Berry Genomics Recent Developments
11.8 Daan Gene
11.8.1 Daan Gene Company Details
11.8.2 Daan Gene Business Overview
11.8.3 Daan Gene Non-invasive Prenatal Genetic Testing Introduction
11.8.4 Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.8.5 Daan Gene Recent Developments
11.9 Annoroad
11.9.1 Annoroad Company Details
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Non-invasive Prenatal Genetic Testing Introduction
11.9.4 Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.9.5 Annoroad Recent Developments
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Non-invasive Prenatal Genetic Testing Introduction
11.10.4 CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2017-2022)
11.10.5 CapitalBio Technology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer